    <div id="boxheadwrap">
        TABLE 2. Recommended regimens: dose and schedule for hepatitis A vaccines
    </div>

    <div id="table2wrap">
        <table>
            <tr class="trheader">
                <th style="text-align:left;">Vaccine</th>

                <th>Age (yrs)</th>

                <th>Dose</th>

                <th>Volume (mL)</th>

                <th>Two-dose schedule (months)*</th>
            </tr>

            <tr>
                <td style="padding-bottom: 1em;  padding-right: .5em;">HAVRIX<sup>†</sup></td>

                <td>1–18</td>

                <td>720 (EL.U.)</td>

                <td>0.5</td>

                <td>0 (6–12)</td>
            </tr>

            <tr>
                <td>&nbsp;</td>

                <td>&nbsp;&gt;18</td>

                <td>1,440 (EL.U.)</td>

                <td>1.0</td>

                <td>0 (6–12)</td>
            </tr>

            <tr class="trspace">
                <td style="padding-bottom: 1em; padding-right: .5em;">VAQTA<sup>§</sup></td>

                <td>1–18</td>

                <td>25 (U)</td>

                <td>0.5</td>

                <td>0 (6–18)</td>
            </tr>

            <tr class="trbottomline">
                <td>&nbsp;</td>

                <td>&nbsp;&gt;18</td>

                <td>50 (U)</td>

                <td>1.0</td>

                <td>0 (6–18)</td>
            </tr>
        </table>

        <div id="bottom_table_text_wrap">
            <strong>Source:</strong> CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55(No. RR-7).

            <div id="box_section_spacer"></div><strong>Abbreviations:</strong> EL.U = Enzyme-linked immunosorbent assay (ELISA) units; U = units.

            <div id="box_section_spacer"></div>

            <div id="hangingindent">
                * 0 months represents timing of the initial dose; subsequent numbers represent months after the initial dose.
            </div>

            <div id="hangingindent">
                <sup>†</sup> Hepatitis A vaccine, inactivated, GlaxoSmithKline Biologicals; this vaccine is also licensed for a 3-dose series in children aged 2–18 years, with 360 EL.U, 0.5 mL doses at 0, 1, and 6–12 months.
            </div>

            <div id="hangingindent">
                <sup>§</sup> Hepatitis A vaccine, inactivated, Merck & Co., Inc.
            </div>
        </div>
    </div>
